Add-on Acquisition • Life Science

Chiesi Farmaceutici Acquires Amryt Pharma

On January 8, 2023, Chiesi Farmaceutici acquired life science company Amryt Pharma for 1.5B USD

Acquisition Context

This is Chiesi Farmaceutici’s 5th transaction in the Life Science sector.
This is Chiesi Farmaceutici’s largest (disclosed) transaction.
This is Chiesi Farmaceutici’s 1st transaction in Ireland.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	January 8, 2023
Target	Amryt Pharma
Sector	Life Science
Buyer(s)	Chiesi Farmaceutici
Deal Type	Add-on Acquisition
Deal Value	1.5B USD
Advisor(s)	Moelis & Co. (Financial) Cooley Gibson, Dunn & Crutcher (Legal)

Target Company

Amryt Pharma

Dublin, Ireland

Amryt Pharma is a pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma is based in Dublin, Ireland.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Chiesi Farmaceutici

Parma, Italy

Category	Company
Founded	1935
Sector	Life Science

DESCRIPTION

Chiesi Farmaceutici is a research-focused international group, with more than 75 years of experience headquartered in Parma (Italy). Chiesi researches, develops and commercializes innovative pharmaceutical solutions in the respiratory therapeutics and specialist medicine areas.

Deal Context for Buyer	#
Overall	6 of 6
Sector: Life Science	5 of 5
Type: Add-on Acquisition	4 of 4
Country: Ireland	1 of 1
Year: 2023	1 of 1
Size (of disclosed)	1 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2017-05-23	Raptor Pharmaceuticals Novato, California, United States Raptor Pharmaceutical Corp. is a bio pharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating and often fatal diseases. Raptor Pharmaceuticals Corp. was established in 2005 and is headquartered in Novato, California.	Buy	$70M

DATE

TARGET

DEAL TYPE

VALUE

2017-05-23

Raptor Pharmaceuticals

Novato, California, United States

Raptor Pharmaceutical Corp. is a bio pharmaceutical company focused on the development and commercialization of transformative therapeutics for rare, debilitating and often fatal diseases. Raptor Pharmaceuticals Corp. was established in 2005 and is headquartered in Novato, California.

Buy

$70M

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Ireland M&A - 2023 M&A